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Abstract
Background: The study determined the one year incidence of post operative cognitive decline (POCD) and evaluated the
effectiveness of an intra-operative anaesthetic intervention in reducing post-operative cognitive impairment in older adults
(over 60 years of age) undergoing elective orthopaedic or abdominal surgery.
Methods and Trial Design: The design was a prospective cohort study with a nested randomised, controlled intervention
trial, using intra-operative BiSpectral index and cerebral oxygen saturation monitoring to enable optimisation of anaesthesia
depth and cerebral oxygen saturation in older adults undergoing surgery.
Results: In the 52 week prospective cohort study (192 surgical patients and 138 controls), mild (x
2=17.9 p,0.0001),
moderate (x
2=7.8 p=0.005) and severe (x
2=5.1 p=0.02) POCD were all significantly higher after 52 weeks in the surgical
patients than among the age matched controls. In the nested RCT, 81 patients were randomized, 73 contributing to the
data analysis (34 intervention, 39 control). In the intervention group mild POCD was significantly reduced at 1, 12 and 52
weeks (Fisher’s Exact Test p=0.018, x
2=5.1 p=0.02 and x
2=5.9 p=0.015), and moderate POCD was reduced at 1 and 52
weeks (x
2=4.4 p=0?037 and x
2=5.4 p=0.02). In addition there was significant improvement in reaction time at all time-
points (Vigilance Reaction Time MWU Z= 22.1 p=0.03, MWU Z=22.7 p=0.004, MWU Z=23.0 p=0.005), in MMSE at one
and 52 weeks (MWU Z=22.9 p=0.003, MWU Z=23.3 p=0.001), and in executive function at 12 and 52 weeks (Trail
Making MWU Z=22.4 p=.0.018, MWU Z=22.4 p=0.019).
Conclusion: POCD is common and persistent in older adults following surgery. The results of the nested RCT indicate the
potential benefits of intra-operative monitoring of anaesthetic depth and cerebral oxygenation as a pragmatic intervention
to reduce post-operative cognitive impairment.
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Introduction
Postoperative cognitive decline (POCD) is recognized as a
common and impactful outcome of surgical procedures in older
adults [1,2]. POCD is most common after cardiac surgery
although up to 40% of people are affected for one week after
non-cardiac procedures. Importantly, up to 15% of people
continue to be affected after three months [3,4]. The first major
study of long term POCD in people over 60 reported an incidence
of 26% one week after surgery and 10% after three months [2].
Whilst the balance of literature supports the persistence of POCD
for at least 3 months, not all studies have demonstrated persistent
change [5]. A systematic review has highlighted attentional
dysfunction as a prominent and sensitive feature of POCD [6].
The clinical significance of POCD, particularly in older indivu-
dals, is emphasised by evidence of the impact it confers on the
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term implications for patients and health service provision very few
studies have assessed POCD for longer than six months post
operatively.
The pathophysiology and causative mechanisms for POCD are
poorly understood [3]. Risk factors include age, preoperative
cognitive function, length of the operation, and postoperative
respiratory complications and infection. Proposed interventions to
modify these factors include monitoring of cerebral oxygen de-
saturation (rSO2) and correcting for duration and depth of
anaesthesia [8–10]. Significant cerebral oxygen desaturation
occurs in up to 30% of patients during major non-cardiac surgery
and preliminary evidence indicates that monitoring improves
outcome by enabling prompt intervention [8,11]. Measurement of
the bispectral index (BIS, Covidien inc, Co, USA) has been
promoted as a variable for depth of anaesthesia. There is high
correlation between BIS and clinical criteria of sedation, and a
recent review reported that BIS-guided anaesthesia improves
outcomes of surgical procedures [12]. It will also be important to
identify biomarkers which robustly predict the extent and
persistence of POCD. The protein S100B has been identified as
a predictor of poor outcome following traumatic brain injury and
so is a promising candidate [13,14].
This 52-week cohort study compared post-operative patients
with age-matched controls. This design is important as it addresses
the unanswered issue of long term cognitive decline. Within the
post-operative group we performed a nested 52-week pragmatic
RCT to evaluate combined BIS and cerebral oxygenation (rSO2)
monitoring using the Somanetics Invos Cerebral Oximeter (SICO,
Covidien inc, Co, USA) to enable optimization of depth of
anaesthesia and to identify significant episodes of cerebral oxygen
de-saturation indicated by a fall in rSO2. Our hypotheses were
that there would continue to be an elevated frequency of impaired
cognition after 52 weeks in the surgical patients compared to the
age matched community cohort, and that an intervention to
enable optimisation of anaesthesia depth and cerebral oxygen
saturation in older adults undergoing surgery would improve
cognitive outcomes one, 12 and 52 weeks post-operatively.
Results
Longitudinal Cohort Study
330 participants were assessed at baseline including 192 surgical
patients and 138 controls. The baseline characteristics are
reported in Table 1. There was no significant difference in age,
baseline MMSE or gender between the two groups.
A total of 256 (78%) participants completed the follow-up
assessments after 52 weeks. There were no significant differences
with respect to age (MWU Z=20.1, p=0.91), baseline MMSE
(MWU Z=20.9, p=0.31) or gender (x
2=0.8 p=0.37) between
participants who completed the follow-up assessment and those
who did not.
Global Decline
At 52 weeks post-operatively there was a significant difference
between patients and controls in all three levels of cognitive
decline. Mild POCD (AACD) was identified in 76% of surgical
patients compared to 50% of non-surgical controls (x
2=17.9
p,0.001). Moderate POCD (MMCI) was identified in 34% of
surgical patients compared to 18% of non-surgical controls
(x
2=7.8 p=0.005). Severe POCD was identified in 11.2% of
surgical patients compared to just 3.8% of non-surgical controls
(x
2=5.1 p=0.02).
52-week RCT
Recruitment for the RCT ran from March 2007 to January
2009, with follow-up of the final participants until January 2010. A
total of 72 participants were randomised to the trial. Participant
flow is summarised in the CONSORT chart in Figure 1.
There were no significant differences between the intervention
and control groups with respect to baseline characteristics (the
mean age of participants at the time of surgery, gender, pre-
operative MMSE or duration of surgery), the type of surgery
received (abdominal, orthopaedic, laparoscopic, open abdominal
aortic aneurysm repairs), or key post-operative medications (opioid
analgesics; psychotropics, antibiotics) (Table 2).
Global Cognitive Decline
At one week post-operatively the treatment group showed
significant reduction in the number of people developing mild
(58% v 89% Fisher’s exact test p=0?018) and moderate (x
2=4.4
57% v 26% p=0?037) POCD. Incidence of severe POCD was
numerically lower in the intervention group (5% v 25% Fisher’s
exact test p=0.12).
At 12 weeks the incidence of mild POCD was significantly
reduced in the intervention group (54% v 82% x
2=5.1 p=0?02).
The levels of moderate and severe POCD were not statistically
different between the intervention and control groups at this
juncture.
At 52 weeks mild and moderate POCD were significantly lower
in the intervention group (84% v 56% x
2=5.9 p=0?015 and
37.5% v 11.1% x
2=5.4 p=0?02). Severe POCD remained
numerically lower in the intervention group (12.5% v 3.7%
Fisher’s exact test p=0.36). The results for the comparisons at 1,
12 and 52 weeks are shown in Table 3. It is striking that the rates
of severe POCD at 52 weeks in the intervention group appear
similar to those in the non-surgical control cohort.
Individual Cognitive Domains
The intervention group showed significantly less decline in
global cognitive function (MMSE) and reaction time at one week.
At 12 weeks the intervention group performed significantly better
in reaction time and executive function (Trail Making), but there
were no significant differences in MMSE. At 52 weeks,
Table 1. Sample Characteristics for the Prospective Cohort Study.
Patient (n=192)
median (IQR)
Control (n=138)
median (IQR) Evaluation
Age 75 (72 to 81) 76 (72 to 79) MWU Z=20.7 p=0.50
Pre-Operative MMSE 28 (27 to 29) 28 (27 to 29) MWU Z=21.1 p=0.25
Male Gender 77 (40%) 51 (37%) x
2=0.8 p=0.56
doi:10.1371/journal.pone.0037410.t001
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compared to the non-intervention arm on the trail making test
and reaction time. In addition, global cognitive benefits were
evident on the MMSE in the intervention group compared to the
control group at 52 weeks. The MMSE is an insensitive measure
of change and the absence of a difference at 12 weeks was
probably due to learning effects. The results are shown fully in
Table 4.
BIS
Both the absolute time in minutes spent outside of the target
range (Intervention, N=31, median=18?0, IQR=42 v control,
N=38, median=33, IQR=94?5, MWU Z=2.3, P=0?02) and
the ratio of time spent inside and outside the target range
(Intervention, Median=7?2, IQR=3?47, v Control, Medi-
an=3?38, IQR=1?84, Z=1?99, P=0?047) were significantly
improved in the intervention group. Time spent outside of the
target BIS range was also significantly correlated with MMSE
one week post surgery (MMSE, R=20?29, P=0?04) and with
trail making at 12 weeks (R=20.35 P=0.013) and at 52 weeks
(R=20.295 P=0.049).
rSO2 Differences
In the intervention group there were five incidences of
significant (.15%) de-saturation, of which three were successfully
treated by the intervention algorithm. There was only one de-
saturation below 50%. In the control group there were seven
significant de-saturations of which six included an rSO2 below
50% (3?3% v 17?1%, Fisher’s exact test P=0?11). Of the patients
who showed an rSO2 below 50% and who were assessed at one
Figure 1. CONSORT chart showing flow of participants through the trial. Assessment of POCD required completion of seven cognitive
assessments which were not all completed for all individuals at all timepoints. Presence/absence of POCD was therefore determined as follows
throughout the trial. Week 1: Intervention group – 19, Control group – 28; Week 12: Intervention group – 24; Control group – 33; Week 52:
Intervention group 27; Control group – 32.
doi:10.1371/journal.pone.0037410.g001
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rSO2.50% v 75% rSO2,50%, Fisher’s exact test P=0?009).
At 12 weeks there was no significant difference between patients
who recorded an rSO2,50% with respect to development of
POCD. At 52 weeks patients who had experienced an rSO2,50%
were significantly more likely to have severe POCD (37.5% v
4.3% Fisher’s Exact test p=0.018).
S100B
S100B levels were correlated with both duration of surgery
(Spearman’s r=0?27, P=0?048) and the number of minutes
during which the BIS index was outside the target range
(Spearman’s r=0?42, P=0?002).
Table 2. Baseline Sample Characteristics for the RCT.
Intervention mean/median
(n=34) (SD/IQR)
Control mean/median
(n=38) (SD/IQR) Evaluation
Age 75?69 (SD 7?40) 75?16 (SD 6.51) t 20?3P=0 ?75
Pre-Operative MMSE 29 (28 to 29) 29 (28 to 29) Z 29P=0 ?37
Duration of Surgery (min) 127 (108 to 150) 133 (110 to 159) Z 20?07 P=0?94
ASA 2 (2 to 2.5) 2 (2 to 2) Z 21?5P=0 ?13
Gender
Male 10 (28%) 12 (32%)
Female 24 (71%) 26 (68%) x
2 0?1d f1P=0 ?75
Type of surgery
Abdominal 6 (18%) 6 (16%)
Orthopaedic 28 (82%) 32 (84%) x
2 0?1d f1P=0 ?74
Type of Medication
% On Opiate analgesics 26 (76%) 27 (71%) x
2 0?5d f1p=0 ?50
% On Psychotropic medication 3 (9%) 3 (8%) Fisher’s Exact test p=1?00
% On Antibiotics 6 (18%) 3 (8%) Fisher’s exact test p=0?28
doi:10.1371/journal.pone.0037410.t002
Table 3. RCT Outcome Comparisons: Post-Operative Cognitive Decline (POCD).
POCD level at 1 week Trial Group No Yes Evaluation
Mild control
intervention
10.7% (n=3)
42.1% (n=8)
89.3% (n=25)
57.9% (n=11)
Fisher’s exact test p=0.018
Moderate control
intervention
42.9% (n=12)
73.7% (n=14)
57.1% (n=16)
26.3% (n=5)
Pearson’s x
2=4.4 p=0.037
Severe control
intervention
75% (n=21)
94.7% (n=18)
25% (n=7)
5.3% (n=1)
Fisher’s exact test p=0.12
POCD level at 12 weeks Trial Group No Yes Evaluation
Mild control
intervention
18.2% (n=6)
45.8% (n=11)
81.8% (n=27)
54.2% (n=13)
x
2=5.1 p=0.02
Moderate control
intervention
72.7% (n=24)
75% (n=18)
27.3% (n=9)
25% (n=6)
x
2=0.04 p=0.85
Severe control
intervention
87.9% (n=29)
91.7% (n=22)
12.1% (n=4)
8.3% (n=2)
x
2=0.2 p=0.65
POCD level at 52 weeks Trial Group No Yes Evaluation
Mild control
intervention
15.6% (n=5)
44.4% (n=12)
84.4% (n=27)
55.6% (n=15)
x
2=5.9 p=0.015
Moderate control
intervention
62.5% (n=20)
88.9% (n=24)
37.5% (n=12)
11.1% (n=3)
x
2=5.4 p=0.02
Severe control
intervention
87.5% (n=28)
96.3% (n=26)
12.5% (n=4)
3.7% (n=1)
Fisher’s exact test p=0.36
POCD at 1 week (n=19 intervention group, n=28 control group). POCD at 12 weeks (n=24 intervention group, n=33 control group). POCD at 52 weeks (n=27
intervention group, n=32 control group).
doi:10.1371/journal.pone.0037410.t003
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The cohort study confirms that there is a significant increased
frequency of cognitive impairment in people over the age of 60
undergoing major non-cardiac surgery, and highlights that a
greater level of cognitive impairment is still evident after 52 weeks
in comparison to age-matched controls. These results emphasise
the clinical importance of POCD and its long term impact on
cognition in this patient group.
The ISPOCD study group identified severe POCD in 10% of
patients at 12 weeks post operatively and 2.8% of controls. In our
prospective cohort study we identified severe POCD in 11.2% of
surgical patients compared to just 3.8% of non-surgical controls at
52 weeks post operatively, whilst the RCT demonstrated severe
POCD in 12.5% of the non intervention surgical patients at the 12
week analysis. Previous literature on Age Associated Cognitive
Decline in adults over 60 has demonstrated the development of
AACD in 54% of normal subjects over 1 year – which is consistent
with the level of mild POCD identified in our control group [27].
The prospective cohort study is the first study to identify
significantly greater levels of global cognitive decline in surgical
patients one year postoperatively. This finding supports the
literature demonstrating a persistent impact of POCD with respect
to patient mortality and welfare over longer term follow-up [28].
The use of a computerised test battery allows for the
identification of subtle cognitive deficits with excellent test/retest
validity whilst minimising the learning effects found in POCD and
may have contribute to the identification of POCD at 52 weeks
postoperatively.
The pilot nested RCT reports the first successful intervention to
reduce cognitive impairment after major non-cardiac surgery in
older people. The RCT indicated that a pragmatic intervention to
optimize anaesthetic depth and maintenance of cerebral oxygen-
ation with BIS and SICO monitoring conferred a significant
reduction in mild and moderate POCD, global cognitive
impairment and attentional impairments at one week post-surgery.
The intervention also conferred sustained benefits in reducing
mild POCD and improving attention, executive performance and
global cognition up to 52 weeks following surgery. The statistical
power was limited, particularly to detect differences in severe
POCD, but the frequencies were lower in the intervention group
and the overall pattern of results indicated clear benefit in the
intervention group. It is notable that in this pilot study, the
intervention appeared to reverse the risk of cognitive impairment
at 52 weeks to a level comparable to the non surgical control
population.
These findings are consistent with the existing literature
although few studies have specifically investigated the effect of
targeting BIS levels to reduce the incidence of POCD. This lack of
research is surprising since a growing body of evidence from cell
and aged animal models (including primates) suggests that general
anaesthetics can be neurotoxic to the developing and aging brain.
Recent reviews have concluded that despite this evidence it would
be premature to change clinical practice since the effect has not
been adequately studied in humans [29,30] and due to robust
conflicting evidence that anaesthetics are well known as neuro-
protectants and may mitigate against the CNS inflammatory
response to surgical trauma [31,32]. This conflict is resolved by the
hypothesis that an optimal range of ‘‘depth of anaesthesia’’ could
Table 4. Outcome Comparisons: Cognitive Outcomes (Change from Baseline between groups).
Measures Intervention Control Evaluation
Week 1 Intervention (n=22) Control (n=29)
MMSE Median (IQR)
Mean (SD)
0?0( 20.25 to 1.00)
0.09 (SD 1.60)
21?0( 23.0 to 0.0)
22.39 (SD 4.09)
MWU Z=22?9P=0 ?003*
Vigilance
Reaction
Time
Median (IQR)
Mean (SD)
20?01 (221.88 to 9.65)
6.39 (SD 80.90)
27?27 (221.36 to 70.32)
27.95 (SD 54.99)
MWU Z=22?1P=0 ?03*
Week 12 Intervention (n=27) Control (n=34) Evaluation
MMSE Median (IQR)
Mean (SD)
0?0( 21.00 to 1.00)
20.04 (SD 1.56)
0?0( 21?00 to 0.00)
20.79 (SD 2.25)
MWU Z=21?4P=0 ?16
Vigilance
Reaction
Time
Median (IQR)
Mean (SD)
29?76 (232.54 to 12.60)
211.73 (SD 33.50)
12.61 (28.58 to 39.27)
13.61 (SD 29.69)
MWU Z=22?6P=0 ?01*
Trail Making Median (IQR)
Mean (SD)
20?35 (20.62 to 0.29)
20.23 (SD 0.73)
0?02 (20.23 to 0.91)
0.47 (SD 1.34)
MWU Z=22?4P=0 ?018*
Week 52 Intervention (n=28) Control (n=32) Evaluation
MMSE Median (IQR)
Mean (SD)
1.00 (0.00 to 1.50)
0.69 (SD 1.47)
0.00 (22.00 to 0.00)
20.94 (SD 2.18)
MWU Z=22.9 p=0.004*
Vigilance
Reaction
Time
Median (IQR)
Mean (SD)
21.71 (226.83 to 12.22)
210.80 (SD 36.28)
23.53 (3.29 to 36.22)
15.10 (SD 40.73)
MWU Z=22.8 p=0.005*
Trail Making Median (IQR)
Mean (SD)
0.31 (20.49 to 0.55)
0.12 (SD 0.68)
20.32 (21.07 to 0.24)
20.47 (SD 0.93)
MWU Z=22.6 p=0.01*
Results presented as both median with upper and lower quartiles and mean with Standard Deviation.
MWU – Mann-Whitney U test, SD – Standard Deviation, IQR – Inter Quartile Range.
*Statistically significant (p,0?05).
doi:10.1371/journal.pone.0037410.t004
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Elsewhere, evidence also supports the usefulness of BIS monitoring
in identifying patients with a good chance of recovery after
ischemic-hypoxic brain injury requiring emergency surgery
[28,33]. In the current study we focussed on potentially modifiable
intraoperative interventions but it is of course important to
interpret this in the context of broader risks including factors
leading to altered individual susceptibility [34].
In the current study, patients receiving the monitoring
intervention were within the optimal BIS target range (40–
6065) for a significantly higher proportion of the intra-operative
period and there was a significant relationship between the
proportion of the intra-operative period spent in this optimal
window and both cognitive outcome and S100B, a marker of brain
injury. It should be acknowledged that the strength of the
correlations are modest. However this provides evidence that the
BIS monitoring was a key component of the intervention.
A further important question is whether SICO monitoring also
contributed to the benefits conferred by the intervention in this
study. There were numerical differences in the number of
patients experiencing significant cerebral oxygen de-saturation in
the two groups, the majority occurring in the control group. As
this difference did not achieve statistical significance caution must
be taken in interpreting this outcome. However, it upholds the
rationale that SICO monitoring may make an important
contribution in a modest sub-group of patients. For example,
in the control group six patients suffered cerebral oxygen
desaturations below 50% and this was associated with an
increased risk of POCD at one week. In comparison, only one
patient experienced this level of cerebral oxygen desaturation in
the intervention group. This is consistent with findings from a
previous study [7,8] which reported that patients in a control
group with intraoperative cerebral desaturation experienced a
longer time to post-anaesthesia care unit (PACU) discharge and
longer hospital stay compared with patients of the treatment
group. The study concluded that using rSO2 monitoring to
manage anaesthesia in elderly patients undergoing major
abdominal surgery reduces the potential exposure of the brain
to hypoxia, and postulated that his might be associated with
decreased effects on cognitive function and shorter PACU and
hospital stay [7,8]. Although this requires further investigation, it
is therefore possible that the SICO monitoring may have
contributed to the impact of the intervention in a sub-group of
participants in the current study.
This study used robust definitions of mild, moderate and severe
POCD, based upon Z scores across several cognitive domains,
using a threshold of 1–2 SD, derived from a pre-trial cohort study.
This approach combines the rigour of previous POCD studies, but
also incorporates measures of mild and moderate POCD
(equivalent to AACD and MMCI, respectively) to enable the
magnitude of cognitive dysfunction and the potential risk of
subsequent dementia to be interpreted in the context of other
studies evaluating cognitive dysfunction in older people.
The results of the cohort study and RCT highlight persistent
impairments of attentional and executive function after major-non
cardiac surgery. Interestingly, other studies examining POCD
have indicated that these aspects of cognitive dysfunction are more
closely linked to impairments of Instrumental Activities of Daily
Living (IADL) than impairments in other cognitive domains
[19,29], emphasising the potential importance of this pattern of
cognitive deficits. Key questions pertain to whether this pattern of
persistent post-operative cognitive deficits indicates a significant
risk for progressive cognitive decline and dementia over longer
term follow-up.
Although the RCT was based on a stipulated power calculation,
the sample is modest in size. In addition as this was an acute post-
surgical study there were a substantial minority of participants who
were not able to complete the one week assessments and this may
have introduced a bias. In addition, multiple statistical evaluations
were undertaken. The data do therefore need to be interpreted
with some caution. The outcome is however extremely encour-
aging and indicates the exciting possibility that a simple and
pragmatic monitoring intervention can significantly reduce post-
operative cognitive impairment. A larger replication study is
urgently indicated and further work to evaluate the impact on
resource utilization will be valuable to determine the potential
cost-effectiveness.
The study highlights significant and persistent cognitive deficits
in older people after major-non cardiac surgery. A preliminary
RCT suggests that a pragmatic intervention focussing upon BIS
and rSO2 can significantly reduce cognitive impairment at one, 12
and 52 weeks post-operatively.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Study Design and Objectives
The study was conducted in two parts. A prospective
longitudinal cohort study was conducted in order to (1) quantify
cognitive decline over a 52 week period comparing a post
operative group with an age, gender and intelligence matched
sample. (2) to determine the sensitivity of the cognitive test battery,
including the computerised CDR assessment for the identification
of POCD.
Within the prospective cohort study a nested 52 week parallel
group, double blind, 1:1 randomized controlled trial, comparing
active anaesthetic monitoring with a control condition was
conducted. To determine whether an intervention to enable
optimisation of anaesthesia depth and cerebral oxygen saturation
(rSO2) in older adults undergoing surgery conferred benefit with
respect to cognitive outcomes at one, 12 and 52 weeks post-
operatively in comparison to usual treatment. The primary
outcome measures were development of mild, moderate and
severe POCD and one, 12 and 52 weeks. Changes in specific
cognitive evaluations were also compared between groups. An
additional analysis examined concentrations of S100B at baseline
and 24 hours post-surgery to determine whether it is a reliable
predictor of outcome in older people.
Recruitment and Inclusion Criteria
Patients from two UK regional teaching hospitals were matched
to control participants from the local regions based on age, gender
and baseline score in the Mini Mental State Exam (MMSE 15). In
Newcastle control participants were recruited from randomly
selected people over the age of 60 from GP lists. In London
controls were identified from spouses of participants. The control
population was stratified into 5 year age bands from which
individuals were randomly selected to match the number of
patients in the postoperative cohort within each 5 year age band.
The health of the controls is likely to reflect that of the general
population for this age.
Patients were eligible for inclusion if they were scheduled to
undertake elective major abdominal or orthopaedic surgery under
general anaesthesia at either centre and were over 60 years of age,
classified as American Society of Anesthesiologists (ASA) as class
RCT of Optimised Anaesthesia to Reduce POCD
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Adequate English was a pre-requisite to enable consent and to
undertake study assessments.
Exclusion Criteria
Participants were excluded if they were unable to complete the
outcome measures, they had a diagnosis of Alzheimer’s disease or
other dementia, if they were undergoing surgical procedures under
regional anaesthesia or if they had delirium at 1 week post surgery.
Randomisation and Blinding
The nested RCT trial was double-blinded; patients and
researchers collecting outcome data were blind to treatment
allocation. Only the anaesthetist delivering the intervention was
aware of the treatment condition. Participants were randomized
according to randomisation lists, generated by the study statistician
in the statistical program package R, which were stratified by age
group (65 to 70, 70 to 75 and over 75). Sealed envelopes
containing the randomization codes were delivered to operating
theatres, and an envelope selected randomly by the anaesthetist.
The randomisation envelope was opened only after the partici-
pant’s eligibility and willingness to participate were re-confirmed
prior to surgery.
Assessments and Outcomes
Patients were assessed using a combination of the MMSE [15]
and the three automated tests of attention from the Cognitive
Drug Research (CDR) system, simple reaction time, choice
reaction time and digit vigilance [16–18]. Assessments were
carried out at baseline (preoperatively for surgical patients) and at
12 months following the baseline assessment for controls. In the
RCT arm assessments were also conducted at 1 and 12 weeks post
baseline assessment. Change over time was measured in relation to
the baseline assessment. The CDR battery was selected as a
sensitive and well validated evaluation of attentional performance
[16], which has previously been shown to be sensitive to cognitive
impairments in post-operative patients [17,18]. Computerised
testing has the added advantage of excellent test/retest validity and
the use of this attentional battery minimises learning effects.
Post operative cognitive decline was classified at three levels -
mild, moderate and severe, building upon previous work focussing
on POCD [19] These levels correspond to measures commonly
used to describe cognitive decline in older people, specifically, age-
associated cognitive decline (AACD), multi-domain mild cognitive
impairment (MMCI) and post-operative cognitive dysfunction
(POCD) [20–23]. The scores were calculated using the ISPOCD Z
score method described previously [2]. The change for individual
participants from baseline was calculated and the control group
was used to remove any learning effect and to provide the standard
deviations for the Z score calculations. The following seven
cognitive measures were used to analyse the level of cognitive
decline: MMSE, simple reaction time, digit vigilance accuracy,
digit vigilance reaction time, choice reaction time accuracy, choice
reaction time and cognitive reaction time. Mild POCD (equivalent
to AACD) was defined as a decline in performance in at least one
of the seven cognitive domains by greater than one standard
deviation (SD). Moderate POCD (equivalent to MMCI) required
an additional decline of at least 1.5 SD in an additional domain,
and severe POCD was defined as a decline of greater than
1.96 SD in at least two domains. The Confusion Assessment
Method (CAM) was used to identify participants with clinically
significant delirium.
In the RCT arm BIS values were compared between groups
according to absolute time (minutes) spent outside of the optimal
range 40–60 (65). Changes in SICO rSO2 values were calculated.
The percentage drop from baseline rSO2 was calculated for each
30 second period.
Plasma levels of the S100B protein were analysed as a
biomarker of brain injury [24]. Blood samples were taken from
participants at baseline and one day post-surgery. Blood was
collected into K2-EDTA vacutainers and centrifuged at 2,000 g
for ten minutes. Plasma was collected and frozen until analysis.
S100B concentrations were measured using a commercially
available ELISA (Alpco Diagnostics, Salem, NH, USA) carried
out to the manufacturer’s instructions.
Statistical Analysis
The RCT was powered a priori as a pilot study. A cohort of 73
patients gives 80% power to the 5% level of significance to detect a
between group difference of 0?33 SD. This threshold was chosen
as the usual one for a meaningful clinical difference i.e. between
0.3 and 0.4 difference in SD [25]. The primary efficacy population
was predefined as all patients who were randomised to receive the
intra-operative anaesthetic intervention or treatment as usual and
completed at least one follow-up assessment.
AnalysiswasconductedusingSPSSsoftware,version17.0(SPSS,
Chicago, IL, USA). Significance was determined as two-sided p
values ,0?05. No correction was made for multiple comparisons.
Comparison of the baseline MMSE, age and gender of the control
and surgical groups was made using the x
2 test, Student’s t test and
Mann–Whitney U test as appropriate. The Kolmogorov-Smirnov
test was used to establish deviation from a normal distribution. The
Figure 2. Protocol for anaesthetic intervention.
doi:10.1371/journal.pone.0037410.g002
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prevalence of mild, moderate and severe cognitive decline between
surgical patients and controls assessed using the x
2 test. Continuous
analysiswasalsoconductedontheindividualcognitivedomainsusing
Student’s t test, the Mann–Whitney U test as appropriate. Demo-
graphicfactorsandclinicalcharacteristicsweresummarisedascounts
(percentages) for categorical variables, mean (standard deviation
[SD]) for normally distributed continuous variables, or median
(interquartile or entire range) for other continuous variables.
Correlation Analysis was conducted to examine the relationship
between the intra-operative monitoring data and the cognitive
outcomevariables.Pearson’sorSpearman’srankcorrelationanalysis
was used depending onthe distribution of the data.
Intervention
All patients received intravenous induction of anaesthesia with
propofol and maintenance with isoflurane. Depth of anaesthesia
and rSO2 were monitored in all participants using BIS and SICO
respectively [26]. Monitoring was performed throughout the
procedure until extubation. In the intervention group this data was
made available to the anaesthetist to enable rigorous optimisation
of the depth of anaesthesia and to identify and facilitate additional
interventions to rectify changes in cerebral oxygen desaturation
(Figure 2). In the control group the BIS and SICO data were
collected, but the anaesthetist was blinded to the monitoring data.
The target optimum BIS range was 40–60 (65).
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